FAPESP is a public foundation, funded by taxpayers in the state of São Paulo, with the mission to support research projects in institutions of higher education and research in all fields of knowledge. São Paulo has a population of 40 million and generates 35% of Brazil’s GNP. The state constitution establishes that 1% of all state tax revenue belongs to the Foundation and the government transfers these funds monthly. The stability of funding and autonomy of the Foundation allow for efficient management of the resources, which has had a sizeable impact: while São Paulo has 22% of the Brazil’s population and 30% of its scientists with doctorates, the state contributes 52% of the country’s scientific articles published in international journals.
The Foundation works in close contact with the scientific community: all proposals are peer reviewed with the help of area panels composed of active researchers. Besides funding research in all fields, the Foundation supports large research programs in Biodiversity, Bioenergy, Global Climate Change, and Neuroscience.
FAPESP maintains cooperation agreements with national and international research funding agencies, institutions of higher educational and research and business enterprises. The international cooperation covers a broad range of countries and agencies (www.fapesp.br/en/6812) including the UK Research Councils, the Agence Nationale de Recherche (ANR) in France, the Deutsche Forschungsgemeinschaft (DFG) in Germany, and the NSF in the U.S. FAPESP offers many programs to support foreign scientists willing to work in research institutions in the state of São Paulo, Brazil. These include: post-doctoral fellowships (www.fapesp.br/en/5427), young investigator awards (www.fapesp.br/en/4479) and visiting researcher grants (www.fapesp.br/147).
Ribeirão Preto Medical School, University of São Paulo
Faculdade de Medicina de Ribeirão Preto (Ribeirão Preto Medical School in Portuguese) is a medical school of the University of São Paulo (USP) located in the city of Ribeirão Preto, state of São Paulo, Brazil, founded 1952. It is considered one of the three best medical schools in the country and a premier medical research center.
Mission: “Providing excellence in higher education, providing training of health professionals with a high level of qualification and potential of leadership, based on ethical, moral, scientific and humanistic principles; training qualified researchers in its graduate programs and produce high-quality innovative research with international insertion, exploring the boundaries of knowledge, but also attentive to the society needs; continuing interaction with the public sector and with the society in order to promote qualified assistance in health and in the dissemination of new knowledge.”
Universidade de São Paulo
The University of São Paulo (USP) is a public University in the Brazilian state of São Paulo founded in 1934. It is the largest Brazilian public University and the country’s most prestigious educational institution, being recently ranked 51-60 worldwide in reputation by the Times Higher Education World University Rankings. USP is one of the largest institutions of higher education in Latin America, with approximately 95,000 enrolled students. Currently, it has eleven campuses, four of them in the city of São Paulo, two in São Carlos, and the remaining campuses in the cities of Bauru, Lorena, Piracicaba, Pirassununga, and Ribeirão Preto. USP is involved in teaching, research, and extension activities in all areas of knowledge. In terms of research, USP is Brazil’s largest research institution, producing more than 25% of the scientific papers published by Brazilian researchers in high quality conferences and journals
SUPERA Park is an innovative environment that promotes knowledge transfer in several types of activities. It is responsible for attracting and retaining technology-based companies, with noteworthy mention to the Health, Biotechnology, Information Technology and Bioenergy industries. Supera is the result of a consortium between the University of São Paulo (USP), Ribeirão Preto City Hall and the Department of Economic Development, Science, Technology and Innovation of the State of São Paulo.
Barcelona Science Park
The Barcelona Science Park is a meeting point where university, business and society come together. Its objective is to promote innovation, particularly in the life sciences. Founded by the University of Barcelona in 1997, it was the first science park in Spain and is an international point of reference today in the promotion of innovation, with more than 2.000 professionals working there. The Barcelona Science Park has as its goals:
- To potentiate quality research with the support of a wide range of technologies
- To revitalise the relation between university and business
- To promote the creation of new companies and institutions
- To further the science-society dialogue and encourage careers in science
At present the park is home to research institutes, companies, an incubator for biotechnology companies and a wide range of research support technology. In addition, it organizes more than 120 activities for the promotion of scientific culture and new careers in science, in which close to 6.000 people participate each year.
University of Barcelona
The University of Barcelona (UB) is the top public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal center of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programs it conducts and the excellence these have achieved.
The UB occupies a competitive position at national, European and worldwide levels in the most important ranking tables designed on a range of variables within different geographical areas. The UB holds a place among the top 250 world universities, according to the new edition of the ranking edited by the British journal The Times Higher Education(THE), and improves its leading position in the QS World University Rankings 2018 thereby becoming the first one in Spain, holding the 156th position worldwide and the 64th in Europe.
The UB is member of the most important international excellence university networks, such as the League of European Research Universities (LERU). It has overseen the creation of two campuses of international excellence: the Barcelona Knowledge Campus (BKC) and the Health University of Barcelona Campus (HUBc). The Barcelona Knowledge Campus (BKC), a project presented jointly by the UB and the Technical University of Catalonia (UPC), merges the two universities’ training, research and innovation potential on Barcelona. The project officially known as the Health Universitat de Barcelona Campus (HUBc) is dedicated to training, research and knowledge transfer, and it brings together two faculties, two university schools and six hospitals all working in various fields of health science.
Institute of Biomedicine of the University of Barcelona
The Institute of Biomedicine of the University of Barcelona (IBUB)(www.ub.edu/ibub) is a transversal research unit that brings together 40 groups from the Faculties of Biology, Pharmacy and Food Sciences and Chemistry. The IBUB was born in 2006 with the aim of identifying, beyond the classical academic structures (departments and faculties), a set of laboratories with complementary scientific activity, capable of generating synergies.
Although the name of the institute is generalist, its research activity is focused on drug and target discovery. The IBUB strategic plan 2018-2021 encompasses a variety of actions for the promotion of a research profile oriented towards the discovery of new biological targets and drugs susceptible to become novel generation drugs. For this purpose, there are, in addition to strong biological foundations -well endorsed by groups with extensive experience in cell and animal models suitable for molecular screening, highly recognized groups in the field of computational design of new drugs and top level laboratories in organic synthesis. These capabilities are structured in two areas, the Integrative Biology Program and the Drug Discovery Program. The ultimate objective of the Institute is to ensure that intramural synergies are translated into an increase in the scale of value of their discoveries, thus providing added value to all those who are likely to be transferred to the industrial sector. It is within this framework that we have as strategic objectives:
- Build and consolidate a multidisciplinary research network with the aim of strengthening biomedical research for discovering new targets and generating innovative drugs.
- Increase the R & D & I potential of IBUB by training young researchers (PhD students and junior postdocs) and supporting those who are in their early stages as independent researchers.
- Provide opportunities for starting research to undergraduate and master level students. This is also a relevant objective given the academic context in which IBUB is located, closely related to very powerful degrees in Biomedical Sciences, Biochemistry, Biotechnology, Chemistry, Biology and Pharmacy. Special attention will be given to all aspects related to internationalization, minority rights and gender balance.
- Transfer the R & D & I developed within the IBUB to the Society
Biocat is the organization that champions the healthcare and life sciences ecosystem in Catalonia working to transform science and technology into regional economic growth as well as social impact.
Biocat focuses its strategy on different key points:
– Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference.
– Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
– Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital.
Set up in 2006 as a public/private foundation, Biocat – along with the government – also drives strategic wide-range policies and projects aimed towards contributing the competiveness of the sector.
- Facilitate relationships and synergies among members of the BioRegion of Catalonia.
- Drive the sector to make it an economic engine in the country.
- Promote the sector on an international level.
- Improve the public’s knowledge and perception of biotechnology.
Fondation Toulouse Cancer Santé
Fondation Toulouse Cancer Santé is a research foundation created by 5 worldwide private companies (Amgen – GSK – Pierre Fabre – Siemens – Total) involved in research and innovation, which has been state-approved May 5th 2006, with a special endowment of ANR, the French agency for research. The aim of the Foundation is to define, promote and finance cooperative actions to develop research and industry in the life sciences and especially in oncology by supporting the highly innovative areas that are: Nano & Bio & Information Technologies and also Radiotherapy and Imaging techniques (“NBI Tech 2 Life”). Based on the Oncopole, in Toulouse, which is a campus, unique in Europe, that brings together on a single site public and private research, academic organizations, industry including pharmaceutical leaders and SMEs, medical and clinical expertise. These actors are committed to working together to achieve a single goal: more effectively fight cancer. By co-organizing the Summer School on Medicines since the first edition, Fondation Toulouse Cancer Santé shows its involvement in multidisciplinary education dedicated to students in life sciences and health, but also in technological sciences.
Université de Montréal
Founded in 1878, the University of Montreal is the largest university in Quebec and the second largest in Canada, with over 64,000 students, including nearly 8,000 from around the world, and with more than 11,000 diplomas awarded at every university level each year. Deeply rooted in Montreal and dedicated to its international mission, the University of Montreal is one of the top universities in the French-speaking world and is ranked 29th on the list of top international institutions in Pharmacy and pharmacology by the QS World University Rankings.
Groupe de recherche universitaire sur le médicament (GRUM)
The University Drug Research Group (GRUM), resarchers at the Université de Montréal, was established in November 2004 in order to develop and support transdisciplinary research, researcher training and technology transfer relating to drug discovery, development and evaluation. It will be a hub for developing and increasing collaborative undertakings and exchanges between scientists exploring all aspects of drug discovery and development, including evaluation of how drugs affect population health.